Assertio Holdings Inc (NASDAQ:ASRT)
| 1.42 BATS BZX Real-Time Price As of 2:35pm ET |  -0.01 / -0.70%Today’s Change | 0.85 Today|||52-Week Range 5.80 | -0.73% Year-to-Date |
Latest ASRT News | Press Releases
| ImmunoGen (IMGN) Surges on Successful Ovarian Cancer Study 10:06am / Zacks.com - Paid Partner Content | Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval Nov 25 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.43 |
| Today’s open | 1.44 |
| Day’s range | 1.41 - 1.49 |
| Volume | 15,687 |
| Average volume (3 months) | 892,063 |
| Market cap | $68.3M |
Data as of 2:35pm ET, 12/01/2021
Growth & Valuation
| Earnings growth (last year) | -630.89% |
| Earnings growth (this year) | -112.06% |
| Earnings growth (next 5 years) | +10.00% |
| Revenue growth (last year) | -26.39% |
| P/E ratio | NM |
| Price/Sales | 0.39 |
| Price/Book | 0.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GLMDGalmed Pharmaceutica... | -0.11 | -4.33% |
| ---- | ||
| ONTXOnconova Therapeutic... | -0.14 | -4.65% |
| ODTOdonate Therapeutics... | -0.04 | -2.44% |
Data as of 2:31pm ET, 12/01/2021
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | $0.08 |
| Annual revenue (last year) | $229.5M |
| Annual profit (last year) | -$217.2M |
| Net profit margin | -94.64% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Lake Forest, Illinois |
Forecasts
